Opaleye Management Has Increased Its Position in Loxo Oncology (LOXO) as Share Value Rose; Vident Investment Advisory Cut Vmware (VMW) Holding as Valuation Declined

May 24, 2018 - By Jacob Smith

Loxo Oncology, Inc. (NASDAQ:LOXO) Logo

James A. Silverman increased its stake in Loxo Oncology (LOXO) by 35.62% based on its latest 2017Q4 regulatory filing with the SEC. Opaleye Management Inc bought 46,300 shares as the company’s stock rose 30.92% while stock markets declined. The hedge fund run by James A. Silverman held 176,300 shares of the health care company at the end of 2017Q4, valued at $14.84M, up from 130,000 at the end of the previous reported quarter. Opaleye Management Inc who had been investing in Loxo Oncology for a number of months, seems to be bullish on the $5.09B market cap company. The stock increased 1.92% or $3.1941 during the last trading session, reaching $169.2841. About 37,443 shares traded. Loxo Oncology, Inc. (NASDAQ:LOXO) has risen 146.80% since May 24, 2017 and is uptrending. It has outperformed by 135.25% the S&P500.

Vident Investment Advisory Llc decreased its stake in Vmware Inc (VMW) by 44.58% based on its latest 2017Q4 regulatory filing with the SEC. Vident Investment Advisory Llc sold 4,267 shares as the company’s stock declined 3.38% with the market. The institutional investor held 5,304 shares of the technology company at the end of 2017Q4, valued at $665,000, down from 9,571 at the end of the previous reported quarter. Vident Investment Advisory Llc who had been investing in Vmware Inc for a number of months, seems to be less bullish one the $55.82B market cap company. The stock decreased 0.36% or $0.5 during the last trading session, reaching $137.73. About 170,692 shares traded. VMware, Inc. (NYSE:VMW) has risen 34.24% since May 24, 2017 and is uptrending. It has outperformed by 22.69% the S&P500.

More important recent VMware, Inc. (NYSE:VMW) news were published by: Seekingalpha.com which released: “Dell talking to shareholders about full VMware merger; DVMT +5.8%” on May 18, 2018, also Globenewswire.com published article titled: “VMware Partners Honored at Annual Partner Leadership Summit”, Seekingalpha.com published: “Dell Going Public Just Got More Interesting” on May 22, 2018. More interesting news about VMware, Inc. (NYSE:VMW) was released by: Streetinsider.com and their article: “VMware (VMW) PT Raised to $155 at Credit Suisse on 1Q19 Preview; ‘Strong Fundamentals at a Discount'” with publication date: May 21, 2018.

Among 48 analysts covering VMware Inc (NYSE:VMW), 20 have Buy rating, 1 Sell and 27 Hold. Therefore 42% are positive. VMware Inc had 177 analyst reports since July 22, 2015 according to SRatingsIntel. The stock of VMware, Inc. (NYSE:VMW) earned “Outperform” rating by BMO Capital Markets on Friday, December 1. BMO Capital Markets maintained the stock with “Market Perform” rating in Thursday, October 27 report. The stock of VMware, Inc. (NYSE:VMW) has “Buy” rating given on Thursday, September 14 by Bank of America. The firm has “Hold” rating given on Tuesday, December 12 by Gabelli. Robert W. Baird downgraded the shares of VMW in report on Wednesday, January 27 to “Neutral” rating. Zacks downgraded the shares of VMW in report on Friday, September 4 to “Hold” rating. Bernstein maintained it with “Market Perform” rating and $67 target in Tuesday, July 26 report. The rating was maintained by Oppenheimer with “Buy” on Friday, June 2. On Tuesday, September 1 the stock rating was maintained by BMO Capital Markets with “Hold”. The rating was initiated by Drexel Hamilton with “Hold” on Friday, October 9.

Vident Investment Advisory Llc, which manages about $243.53M and $2.22 billion US Long portfolio, upped its stake in Anthem Inc (NYSE:ANTM) by 3,052 shares to 18,920 shares, valued at $4.26 million in 2017Q4, according to the filing. It also increased its holding in Exelon Corp (NYSE:EXC) by 11,013 shares in the quarter, for a total of 106,824 shares, and has risen its stake in Eaton Vance Ltd Dur Income F (EVV).

Investors sentiment decreased to 0.87 in 2017 Q4. Its down 0.35, from 1.22 in 2017Q3. It dropped, as 41 investors sold VMW shares while 158 reduced holdings. 67 funds opened positions while 106 raised stakes. 88.47 million shares or 0.79% more from 87.77 million shares in 2017Q3 were reported. Honeywell Int stated it has 170,000 shares. 120,400 were reported by Pggm. Colony Gru Llc owns 1,885 shares. Ahl Ptnrs Ltd Liability Partnership, a United Kingdom-based fund reported 66,868 shares. Shamrock Asset Mngmt Limited, a Texas-based fund reported 332 shares. 932,280 were reported by Goldman Sachs Grp Inc. Comerica has 5,420 shares. 223,040 were reported by Invesco Limited. University Of Texas Investment Managment stated it has 0.09% in VMware, Inc. (NYSE:VMW). Weiss Multi owns 12,500 shares or 0.04% of their US portfolio. Adirondack Trust Communications stated it has 0.01% in VMware, Inc. (NYSE:VMW). Asset Management One Ltd stated it has 0.04% of its portfolio in VMware, Inc. (NYSE:VMW). Sandler Capital Management owns 45,400 shares. Principal Gru Inc owns 140,500 shares. Burney Com accumulated 0.3% or 42,216 shares.

Since December 8, 2017, it had 0 buys, and 4 sales for $4.77 million activity. The insider Raghuram Rangarajan (Raghu) sold 23,381 shares worth $2.82 million. Carli Maurizio sold $335,220 worth of stock or 2,581 shares.

Investors sentiment decreased to 0.97 in 2017 Q4. Its down 0.76, from 1.73 in 2017Q3. It worsened, as 29 investors sold LOXO shares while 43 reduced holdings. 23 funds opened positions while 47 raised stakes. 124.82 million shares or 329.48% more from 29.06 million shares in 2017Q3 were reported. Tocqueville Asset Mgmt LP holds 0% or 4,000 shares in its portfolio. Los Angeles Capital Mngmt Equity Rech Incorporated accumulated 4,516 shares or 0% of the stock. Denver Investment Advsrs Lc invested 0.02% in Loxo Oncology, Inc. (NASDAQ:LOXO). Prelude Capital Mngmt Ltd holds 0% of its portfolio in Loxo Oncology, Inc. (NASDAQ:LOXO) for 361 shares. Aqr Capital Mgmt Lc has 23,764 shares. Smith Asset Mgmt Ltd Partnership reported 0.01% in Loxo Oncology, Inc. (NASDAQ:LOXO). Invesco Limited reported 0.01% stake. 99,836 were reported by Axa. Dafna Capital Ltd Com holds 13.42% or 296,000 shares. Jpmorgan Chase & owns 65,431 shares or 0% of their US portfolio. Deutsche National Bank Ag reported 128,669 shares. Principal Financial Group Incorporated has 0% invested in Loxo Oncology, Inc. (NASDAQ:LOXO) for 8,442 shares. State Common Retirement Fund reported 24,300 shares stake. Prudential Financial holds 0% or 38,070 shares in its portfolio. The Colorado-based Public Employees Retirement Association Of Colorado has invested 0% in Loxo Oncology, Inc. (NASDAQ:LOXO).

Since December 8, 2017, it had 0 insider purchases, and 23 selling transactions for $76.68 million activity. Kunkel Lori Anne sold $663,378 worth of Loxo Oncology, Inc. (NASDAQ:LOXO) on Friday, April 20. On Tuesday, January 16 Van Naarden Jacob sold $271,866 worth of Loxo Oncology, Inc. (NASDAQ:LOXO) or 3,082 shares. Bilenker Joshua H. also sold $1.32 million worth of Loxo Oncology, Inc. (NASDAQ:LOXO) on Tuesday, January 16. 250,000 Loxo Oncology, Inc. (NASDAQ:LOXO) shares with value of $20.13 million were sold by AISLING CAPITAL III LP. 15,000 shares were sold by Naider Avi Z., worth $1.50 million on Monday, January 22. The insider ORBIMED ADVISORS LLC sold $20.63 million.

More notable recent Loxo Oncology, Inc. (NASDAQ:LOXO) news were published by: Nasdaq.com which released: “Loxo Oncology Announces Details of LOXO-292 Clinical Data Presentations at the 2018 American Society of Clinical …” on May 16, 2018, also Seekingalpha.com with their article: “Your Daily Pharma Scoop: Loxo Outstanding Results, Cimzia Trial Success, Audentes Positive Data” published on May 17, 2018, Nasdaq.com published: “Mid-Afternoon Market Update: Dow Turns Lower; JC Penney Shares Plunge” on May 17, 2018. More interesting news about Loxo Oncology, Inc. (NASDAQ:LOXO) were released by: Seekingalpha.com and their article: “Spotlight On Gambling Reset And Banking Bill” published on May 19, 2018 as well as Nasdaq.com‘s news article titled: “Loxo Oncology Reports First Quarter 2018 Financial Results” with publication date: May 08, 2018.

Among 11 analysts covering Loxo Oncology Inc (NASDAQ:LOXO), 10 have Buy rating, 1 Sell and 0 Hold. Therefore 91% are positive. Loxo Oncology Inc had 38 analyst reports since July 29, 2015 according to SRatingsIntel. The company was maintained on Thursday, November 2 by Stifel Nicolaus. The stock of Loxo Oncology, Inc. (NASDAQ:LOXO) earned “Sell” rating by Zacks on Friday, August 28. The firm has “Buy” rating given on Monday, March 5 by Citigroup. The firm has “Equal-Weight” rating given on Wednesday, March 21 by Morgan Stanley. The firm earned “Buy” rating on Monday, June 5 by BTIG Research. The rating was initiated by Citigroup with “Buy” on Monday, January 18. The stock of Loxo Oncology, Inc. (NASDAQ:LOXO) has “Buy” rating given on Tuesday, November 14 by JMP Securities. The rating was maintained by Stifel Nicolaus on Monday, June 5 with “Buy”. Cowen & Co maintained Loxo Oncology, Inc. (NASDAQ:LOXO) on Monday, June 5 with “Buy” rating. The rating was maintained by Citigroup on Wednesday, March 16 with “Buy”.

VMware, Inc. (NYSE:VMW) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter:


>